한글목차

오가노이드 시장 - 조사 범위

TMR 조사 보고서 '세계의 오가노이드 시장'은 2025-2035년 예측 기간 동안 시장 지표에 대한 가치 있는 인사이트를 얻기 위해 과거 및 현재의 성장 동향과 기회를 연구합니다. 2025년 기준 연도, 2035년 예측연도로 2025-2035년 세계의 수술 장비 시장 수익과 예측을 제공합니다. 2025년 기준 연도, 2035년 예측연도로, 2025-2035년 세계의 오가노이드 시장 수익과 예측을 제공합니다. 또한 2025-2035년 세계의 오가노이드 시장 연평균 성장률(CAGR%)도 제공합니다.

본 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서 분석가들은 KOL(Key Opinion Leader), 업계 리더 및 의견 형성자들과의 인터뷰를 수행하는 등 연구 노력의 대부분을 차지했습니다. 2차 연구는 주요 업체들의 제품 문헌, 연차 보고서, 보도 자료 및 관련 문서를 참조하여 오가노이드 시장을 파악했습니다.

본 보고서는 세계의 오가노이드 시장 경쟁 구도를 조사했습니다. 세계의 오가노이드 시장에서 활동하는 주요 업체들을 식별하고, 각 업체를 다양한 속성 측면에서 프로파일링했습니다. 기업 개요, 재무 현황, 최근 동향, SWOT 분석은 본 보고서에서 프로파일링된 세계의 오가노이드 시장 참여 기업 속성입니다.

세계 오가노이드 시장 보고서에서 다루는 주요 질문

• 세계의 오가노이드 시장 비즈니스 기회는 무엇인가?
• 시장의 주요 촉진요인, 시장 성장 억제요인, 기회, 위협은 무엇인가?
• 예측 기간 동안 가장 빠른 CAGR로 성장하는 지역 시장은 어디인가?
• 2035년 세계에서 가장 높은 수익을 올릴 것으로 예상되는 부문은 무엇인가?
• 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상되는 부문은 무엇인가?
• 세계 시장에서 사업 전개하는 각 기업 시장 포지션은 무엇인가?

오가노이드 시장 - 조사 목적 및 조사 기법

본 조사 보고서는 세계의 오가노이드 시장에 대해 연구 및 분석한 보고서입니다. 본 보고서는 연구 목적과 시장 내 주요 공급업체 및 유통업체, 제품 승인 관련 규제 환경에 대한 상세한 설명을 제공합니다.

독해 편의성을 위해 보고서는 장별 구성으로 편성되었으며, 각 부분은 소단위로 세분화되었습니다. 보고서는 적절히 배치된 방대한 양의 그래프와 표로 구성됩니다. 주요 부문의 실제 및 예상 값을 시각적으로 표현한 내용은 독자에게 시각적 매력을 제공합니다. 이는 또한 과거와 예측 기간 말 기준 주요 부문의 시장 점유율 비교를 가능하게 합니다.

본 보고서는 세계 오가노이드 시장을 제품, 최종 사용자 및 지역별로 분석합니다. 각 기준의 주요 부문을 상세하게 조사하고 2035년 말 시점의 각 부문에 대한 시장 점유율을 제공합니다. 이러한 가치 있는 인사이트는 시장 관계자들이 전 세계 오가노이드 시장에 대한 투자에 대한 충분한 정보를 바탕으로 비즈니스 의사 결정을 내릴 수 있습니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

• 소개
• 개요
• 시장 역학
• 세계의 오가노이드 시장 분석과 예측(2020-2035년)

제5장 주요 인사이트

• 주요 지역 및 국가 의료비 지출
• 오가노이드 기술의 최근 진보
• 오가노이드의 가격 동향
• 주요 지역 및 국가 규제 시나리오
• Porter's Five Forces 분석
• PESTEL 분석
• 밸류체인 분석
• 최종 사용자를 위한 주요 구매 지표
• 신규 시장 참가자를 위한 시장 개척 전략
• 주요 업계 이벤트(파트너십, 콜라보레이션, 제품 승인, 합병 및 인수)
• 주요 경쟁이 제공하는 주요 제품 벤치 마크

제6장 세계 시장 분석과 예측 : 오가노이드 유형별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 오가노이드 유형별(2020-2035년)
  • 위 오가노이드
  • 장 오가노이드
  • 간 오가노이드
  • 폐 오가노이드
  • 뇌 오가노이드
  • 신장 오가노이드
  • 대장 오가노이드
  • 유방 오가노이드
  • 전립선 오가노이드
  • 피부 오가노이드
  • 망막 오가노이드
  • 기타
• 시장의 매력 : 오가노이드 유형별

제7장 세계 시장 분석과 예측 : 공급원별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 공급원별(2020-2035년)
  • 다능성 줄기세포(PSC)
    • 배아 줄기 세포(ES 세포)
    • 인공 다능성 줄기세포(iPSC)
  • 성체 줄기세포(ASC)
  • 환자 유래의 오가노이드
• 시장의 매력 : 공급원별

제8장 세계 시장 분석과 예측 : 용도별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 용도별(2020-2035년)
  • 발생 생물학
  • 재생 의료
  • 질병 모델링
  • 약물의 독성 및 효능 시험
  • 바이오마커 발견
  • 기타
• 시장의 매력 : 용도별

제9장 세계 시장 분석과 예측 : 사용성별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 사용성별(2020-2035년)
  • 바로 사용할 수 있는 오가노이드
  • 맞춤형 오가노이드
• 시장의 매력 : 사용성별

제10장 세계 시장 분석과 예측 : 보관 조건별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 보관 조건별(2020-2035년)
  • 상온 보존 오가노이드
  • 냉동 보존 오가노이드
• 시장의 매력 : 보관 조건별

제11장 세계 시장 분석과 예측 : 최종 사용자별

• 소개 및 정의
• 주요 조사 결과 및 진전
• 시장 매출 예측 : 최종 사용자별(2020-2035년)
  • 제약 및 생명공학 기업
  • 계약연구기관(CRO)
  • 학술기관 및 연구기관
• 시장의 매력 : 최종 사용자별

제12장 세계 시장 분석과 예측 : 지역별

• 주요 조사 결과
• 시장 매출 예측 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카
• 시장의 매력 : 지역별

제13장 북미 시장 분석과 예측

• 미국
• 캐나다

제14장 유럽 시장 분석과 예측

• 독일
• 영국
• 프랑스
• 이탈리아
• 스페인
• 스위스
• 네덜란드
• 기타 유럽

제15장 아시아태평양 시장 분석과 예측

• 중국
• 인도
• 일본
• 한국
• 호주 및 뉴질랜드
• 기타 아시아태평양

제16장 라틴아메리카 시장 분석과 예측

• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카

제17장 중동 및 아프리카 시장 분석과 예측

• GCC 국가
• 남아프리카
• 기타 중동 및 아프리카

제18장 경쟁 구도

• 시장 기업 : 경쟁 매트릭스(기업 등급별, 규모별)
• 시장 점유율 분석기업별(2024년)
• 기업 프로파일
  • Danaher Corporation
  • Merck KGaA
  • 3Dnamics Inc.
  • ATCC
  • STEMCELL Technologies
  • CelVivo ApS
  • Emulate, Inc.
  • Newcells Biotech
  • ACROBiosystems
  • Corning Incorporated
  • Pandorum Technologies Pvt. Ltd.
  • MIMETAS BV
  • Organovo Holdings Inc.
  • Crown Bioscience
  • OrganoTherapeutics SARL

영문목차

Organoids Market- Scope of Report

TMR's report on the global Organoids Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Organoids Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Organoids Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Organoids Market .

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Organoids Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Organoids Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Organoids Market .

The report delves into the competitive landscape of the global Organoids Market . Key players operating in the global Organoids Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Organoids Marketprofiled in this report.

Key Questions Answered in Global Organoids MarketReport:

• What are the opportunities in the global Organoids Market ?
• What are the major drivers, restraints, opportunities, and threats in the Market ?
• Which regional Market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the Market positions of different companies operating in the global Market ?

Organoids Market- Research Objectives and Research Approach

The comprehensive report on the global Organoids Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Organoids Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Organoids Market .

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Organoids Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Organoids Market Analysis and Forecasts, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. Recent Advancements in Organoid Technology
• 5.3. Pricing Trends for Organoids
• 5.4. Regulatory Scenario across Key Regions / Countries
• 5.5. PORTER's Five Forces Analysis
• 5.6. PESTEL Analysis
• 5.7. Value Chain Analysis
• 5.8. Key Purchase Metrics for End-users
• 5.9. Go-to-Market Strategy for New Market Entrants
• 5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
• 5.11. Benchmarking of Key Products Offered by the Leading Competitors

6. Global Organoids Market Analysis and Forecasts, By Type of Organoid

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Type of Organoid, 2020 to 2035
  • 6.3.1. Stomach Organoids
  • 6.3.2. Intestinal Organoids
  • 6.3.3. Liver Organoids
  • 6.3.4. Lung Organoids
  • 6.3.5. Brain Organoids
  • 6.3.6. Kidney Organoids
  • 6.3.7. Colorectal Organoids
  • 6.3.8. Breast Organoids
  • 6.3.9. Prostate Organoids
  • 6.3.10. Skin Organoids
  • 6.3.11. Retina Organoids
  • 6.3.12. Others
• 6.4. Market Attractiveness By Type of Organoid

7. Global Organoids Market Analysis and Forecasts, By Source

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Source, 2020 to 2035
  • 7.3.1. Pluripotent Stem Cells (PSCs)
    • 7.3.1.1. Embryonic Stem Cells (ESCs)
    • 7.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
  • 7.3.2. Adult Stem Cells (ASCs)
  • 7.3.3. Patient-derived Organoids
• 7.4. Market Attractiveness By Source

8. Global Organoids Market Analysis and Forecasts, By Application

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Application, 2020 to 2035
  • 8.3.1. Developmental Biology
  • 8.3.2. Regenerative Medicine
  • 8.3.3. Disease Modelling
  • 8.3.4. Drug Toxicity and Efficacy Testing
  • 8.3.5. Biomarker Discovery
  • 8.3.6. Others
• 8.4. Market Attractiveness By Application

9. Global Organoids Market Analysis and Forecasts, By Usability

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By Usability, 2020 to 2035
  • 9.3.1. Ready-to-Use Organoids
  • 9.3.2. Customizable Organoids
• 9.4. Market Attractiveness By Usability

10. Global Organoids Market Analysis and Forecasts, By Storage Conditions

• 10.1. Introduction & Definition
• 10.2. Key Findings / Developments
• 10.3. Market Value Forecast By Storage Conditions, 2020 to 2035
  • 10.3.1. Shelf-stable Organoids
  • 10.3.2. Cryopreserved Organoids
• 10.4. Market Attractiveness By Storage Conditions

11. Global Organoids Market Analysis and Forecasts, By End-user

• 11.1. Introduction & Definition
• 11.2. Key Findings / Developments
• 11.3. Market Value Forecast By End-user, 2020 to 2035
  • 11.3.1. Pharmaceutical and Biotechnology Companies
  • 11.3.2. Contract Research Organizations (CROs)
  • 11.3.3. Academic and Research Institutions
• 11.4. Market Attractiveness By End-user

12. Global Organoids Market Analysis and Forecasts, By Region

• 12.1. Key Findings
• 12.2. Market Value Forecast By Region
  • 12.2.1. North America
  • 12.2.2. Europe
  • 12.2.3. Asia Pacific
  • 12.2.4. Latin America
  • 12.2.5. Middle East & Africa
• 12.3. Market Attractiveness By Region

13. North America Organoids Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Type of Organoid, 2020 to 2035
  • 13.2.1. Stomach Organoids
  • 13.2.2. Intestinal Organoids
  • 13.2.3. Liver Organoids
  • 13.2.4. Lung Organoids
  • 13.2.5. Brain Organoids
  • 13.2.6. Kidney Organoids
  • 13.2.7. Colorectal Organoids
  • 13.2.8. Breast Organoids
  • 13.2.9. Prostate Organoids
  • 13.2.10. Skin Organoids
  • 13.2.11. Retina Organoids
  • 13.2.12. Others
• 13.3. Market Value Forecast By Source, 2020 to 2035
  • 13.3.1. Pluripotent Stem Cells (PSCs)
    • 13.3.1.1. Embryonic Stem Cells (ESCs)
    • 13.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
  • 13.3.2. Adult Stem Cells (ASCs)
  • 13.3.3. Patient-derived Organoids
• 13.4. Market Value Forecast By Application, 2020 to 2035
  • 13.4.1. Developmental Biology
  • 13.4.2. Regenerative Medicine
  • 13.4.3. Disease Modelling
  • 13.4.4. Drug Toxicity and Efficacy Testing
  • 13.4.5. Biomarker Discovery
  • 13.4.6. Others
• 13.5. Market Value Forecast By Usability, 2020 to 2035
  • 13.5.1. Ready-to-Use Organoids
  • 13.5.2. Customizable Organoids
• 13.6. Market Value Forecast By Storage Conditions, 2020 to 2035
  • 13.6.1. Shelf-stable Organoids
  • 13.6.2. Cryopreserved Organoids
• 13.7. Market Value Forecast By End-user, 2020 to 2035
  • 13.7.1. Pharmaceutical and Biotechnology Companies
  • 13.7.2. Contract Research Organizations (CROs)
  • 13.7.3. Academic and Research Institutions
• 13.8. Market Value Forecast By Country , 2020 to 2035
  • 13.8.1. U.S.
  • 13.8.2. Canada
• 13.9. Market Attractiveness Analysis
  • 13.9.1. By Type of Organoid
  • 13.9.2. By Source
  • 13.9.3. By Application
  • 13.9.4. By Usability
  • 13.9.5. By Storage Conditions
  • 13.9.6. By End-user
  • 13.9.7. By Country

14. Europe Organoids Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Type of Organoid, 2020 to 2035
  • 14.2.1. Stomach Organoids
  • 14.2.2. Intestinal Organoids
  • 14.2.3. Liver Organoids
  • 14.2.4. Lung Organoids
  • 14.2.5. Brain Organoids
  • 14.2.6. Kidney Organoids
  • 14.2.7. Colorectal Organoids
  • 14.2.8. Breast Organoids
  • 14.2.9. Prostate Organoids
  • 14.2.10. Skin Organoids
  • 14.2.11. Retina Organoids
  • 14.2.12. Others
• 14.3. Market Value Forecast By Source, 2020 to 2035
  • 14.3.1. Pluripotent Stem Cells (PSCs)
    • 14.3.1.1. Embryonic Stem Cells (ESCs)
    • 14.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
  • 14.3.2. Adult Stem Cells (ASCs)
  • 14.3.3. Patient-derived Organoids
• 14.4. Market Value Forecast By Application, 2020 to 2035
  • 14.4.1. Developmental Biology
  • 14.4.2. Regenerative Medicine
  • 14.4.3. Disease Modelling
  • 14.4.4. Drug Toxicity and Efficacy Testing
  • 14.4.5. Biomarker Discovery
  • 14.4.6. Others
• 14.5. Market Value Forecast By Usability, 2020 to 2035
  • 14.5.1. Ready-to-Use Organoids
  • 14.5.2. Customizable Organoids
• 14.6. Market Value Forecast By Storage Conditions, 2020 to 2035
  • 14.6.1. Shelf-stable Organoids
  • 14.6.2. Cryopreserved Organoids
• 14.7. Market Value Forecast By End-user, 2020 to 2035
  • 14.7.1. Pharmaceutical and Biotechnology Companies
  • 14.7.2. Contract Research Organizations (CROs)
  • 14.7.3. Academic and Research Institutions
• 14.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
  • 14.8.1. Germany
  • 14.8.2. UK
  • 14.8.3. France
  • 14.8.4. Italy
  • 14.8.5. Spain
  • 14.8.6. Switzerland
  • 14.8.7. The Netherlands
  • 14.8.8. Rest of Europe
• 14.9. Market Attractiveness Analysis
  • 14.9.1. By Type of Organoid
  • 14.9.2. By Source
  • 14.9.3. By Application
  • 14.9.4. By Usability
  • 14.9.5. By Storage Conditions
  • 14.9.6. By End-user
  • 14.9.7. By Country / Sub-region

15. Asia Pacific Organoids Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Type of Organoid, 2020 to 2035
  • 15.2.1. Stomach Organoids
  • 15.2.2. Intestinal Organoids
  • 15.2.3. Liver Organoids
  • 15.2.4. Lung Organoids
  • 15.2.5. Brain Organoids
  • 15.2.6. Kidney Organoids
  • 15.2.7. Colorectal Organoids
  • 15.2.8. Breast Organoids
  • 15.2.9. Prostate Organoids
  • 15.2.10. Skin Organoids
  • 15.2.11. Retina Organoids
  • 15.2.12. Others
• 15.3. Market Value Forecast By Source, 2020 to 2035
  • 15.3.1. Pluripotent Stem Cells (PSCs)
    • 15.3.1.1. Embryonic Stem Cells (ESCs)
    • 15.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
  • 15.3.2. Adult Stem Cells (ASCs)
  • 15.3.3. Patient-derived Organoids
• 15.4. Market Value Forecast By Application, 2020 to 2035
  • 15.4.1. Developmental Biology
  • 15.4.2. Regenerative Medicine
  • 15.4.3. Disease Modelling
  • 15.4.4. Drug Toxicity and Efficacy Testing
  • 15.4.5. Biomarker Discovery
  • 15.4.6. Others
• 15.5. Market Value Forecast By Usability, 2020 to 2035
  • 15.5.1. Ready-to-Use Organoids
  • 15.5.2. Customizable Organoids
• 15.6. Market Value Forecast By Storage Conditions, 2020 to 2035
  • 15.6.1. Shelf-stable Organoids
  • 15.6.2. Cryopreserved Organoids
• 15.7. Market Value Forecast By End-user, 2020 to 2035
  • 15.7.1. Pharmaceutical and Biotechnology Companies
  • 15.7.2. Contract Research Organizations (CROs)
  • 15.7.3. Academic and Research Institutions
• 15.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
  • 15.8.1. China
  • 15.8.2. India
  • 15.8.3. Japan
  • 15.8.4. South Korea
  • 15.8.5. Australia & New Zealand
  • 15.8.6. Rest of Asia Pacific
• 15.9. Market Attractiveness Analysis
  • 15.9.1. By Type of Organoid
  • 15.9.2. By Source
  • 15.9.3. By Application
  • 15.9.4. By Usability
  • 15.9.5. By Storage Conditions
  • 15.9.6. By End-user
  • 15.9.7. By Country / Sub-region

16. Latin America Organoids Market Analysis and Forecast

• 16.1. Introduction
  • 16.1.1. Key Findings
• 16.2. Market Value Forecast By Type of Organoid, 2020 to 2035
  • 16.2.1. Stomach Organoids
  • 16.2.2. Intestinal Organoids
  • 16.2.3. Liver Organoids
  • 16.2.4. Lung Organoids
  • 16.2.5. Brain Organoids
  • 16.2.6. Kidney Organoids
  • 16.2.7. Colorectal Organoids
  • 16.2.8. Breast Organoids
  • 16.2.9. Prostate Organoids
  • 16.2.10. Skin Organoids
  • 16.2.11. Retina Organoids
  • 16.2.12. Others
• 16.3. Market Value Forecast By Source, 2020 to 2035
  • 16.3.1. Pluripotent Stem Cells (PSCs)
    • 16.3.1.1. Embryonic Stem Cells (ESCs)
    • 16.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
  • 16.3.2. Adult Stem Cells (ASCs)
  • 16.3.3. Patient-derived Organoids
• 16.4. Market Value Forecast By Application, 2020 to 2035
  • 16.4.1. Developmental Biology
  • 16.4.2. Regenerative Medicine
  • 16.4.3. Disease Modelling
  • 16.4.4. Drug Toxicity and Efficacy Testing
  • 16.4.5. Biomarker Discovery
  • 16.4.6. Others
• 16.5. Market Value Forecast By Usability, 2020 to 2035
  • 16.5.1. Ready-to-Use Organoids
  • 16.5.2. Customizable Organoids
• 16.6. Market Value Forecast By Storage Conditions, 2020 to 2035
  • 16.6.1. Shelf-stable Organoids
  • 16.6.2. Cryopreserved Organoids
• 16.7. Market Value Forecast By End-user, 2020 to 2035
  • 16.7.1. Pharmaceutical and Biotechnology Companies
  • 16.7.2. Contract Research Organizations (CROs)
  • 16.7.3. Academic and Research Institutions
• 16.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
  • 16.8.1. Brazil
  • 16.8.2. Mexico
  • 16.8.3. Argentina
  • 16.8.4. Rest of Latin America
• 16.9. Market Attractiveness Analysis
  • 16.9.1. By Type of Organoid
  • 16.9.2. By Source
  • 16.9.3. By Application
  • 16.9.4. By Usability
  • 16.9.5. By Storage Conditions
  • 16.9.6. By End-user
  • 16.9.7. By Country / Sub-region

17. Middle East & Africa Organoids Market Analysis and Forecast

• 17.1. Introduction
  • 17.1.1. Key Findings
• 17.2. Market Value Forecast By Type of Organoid, 2020 to 2035
  • 17.2.1. Stomach Organoids
  • 17.2.2. Intestinal Organoids
  • 17.2.3. Liver Organoids
  • 17.2.4. Lung Organoids
  • 17.2.5. Brain Organoids
  • 17.2.6. Kidney Organoids
  • 17.2.7. Colorectal Organoids
  • 17.2.8. Breast Organoids
  • 17.2.9. Prostate Organoids
  • 17.2.10. Skin Organoids
  • 17.2.11. Retina Organoids
  • 17.2.12. Others
• 17.3. Market Value Forecast By Source, 2020 to 2035
  • 17.3.1. Pluripotent Stem Cells (PSCs)
    • 17.3.1.1. Embryonic Stem Cells (ESCs)
    • 17.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
  • 17.3.2. Adult Stem Cells (ASCs)
  • 17.3.3. Patient-derived Organoids
• 17.4. Market Value Forecast By Application, 2020 to 2035
  • 17.4.1. Developmental Biology
  • 17.4.2. Regenerative Medicine
  • 17.4.3. Disease Modelling
  • 17.4.4. Drug Toxicity and Efficacy Testing
  • 17.4.5. Biomarker Discovery
  • 17.4.6. Others
• 17.5. Market Value Forecast By Usability, 2020 to 2035
  • 17.5.1. Ready-to-Use Organoids
  • 17.5.2. Customizable Organoids
• 17.6. Market Value Forecast By Storage Conditions, 2020 to 2035
  • 17.6.1. Shelf-stable Organoids
  • 17.6.2. Cryopreserved Organoids
• 17.7. Market Value Forecast By End-user, 2020 to 2035
  • 17.7.1. Pharmaceutical and Biotechnology Companies
  • 17.7.2. Contract Research Organizations (CROs)
  • 17.7.3. Academic and Research Institutions
• 17.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
  • 17.8.1. GCC Countries
  • 17.8.2. South Africa
  • 17.8.3. Rest of Middle East & Africa
• 17.9. Market Attractiveness Analysis
  • 17.9.1. By Type of Organoid
  • 17.9.2. By Source
  • 17.9.3. By Application
  • 17.9.4. By Usability
  • 17.9.5. By Storage Conditions
  • 17.9.6. By End-user
  • 17.9.7. By Country / Sub-region

18. Competition Landscape

• 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 18.2. Market Share Analysis By Company (2024)
• 18.3. Company Profiles
  • 18.3.1. Danaher Corporation
    • 18.3.1.1. Company Overview
    • 18.3.1.2. Financial Overview
    • 18.3.1.3. Product Portfolio
    • 18.3.1.4. Business Strategies
    • 18.3.1.5. Recent Developments
  • 18.3.2. Merck KGaA
    • 18.3.2.1. Company Overview
    • 18.3.2.2. Financial Overview
    • 18.3.2.3. Product Portfolio
    • 18.3.2.4. Business Strategies
    • 18.3.2.5. Recent Developments
  • 18.3.3. 3Dnamics Inc.
    • 18.3.3.1. Company Overview
    • 18.3.3.2. Financial Overview
    • 18.3.3.3. Product Portfolio
    • 18.3.3.4. Business Strategies
    • 18.3.3.5. Recent Developments
  • 18.3.4. ATCC
    • 18.3.4.1. Company Overview
    • 18.3.4.2. Financial Overview
    • 18.3.4.3. Product Portfolio
    • 18.3.4.4. Business Strategies
    • 18.3.4.5. Recent Developments
  • 18.3.5. STEMCELL Technologies
    • 18.3.5.1. Company Overview
    • 18.3.5.2. Financial Overview
    • 18.3.5.3. Product Portfolio
    • 18.3.5.4. Business Strategies
    • 18.3.5.5. Recent Developments
  • 18.3.6. CelVivo ApS
    • 18.3.6.1. Company Overview
    • 18.3.6.2. Financial Overview
    • 18.3.6.3. Product Portfolio
    • 18.3.6.4. Business Strategies
    • 18.3.6.5. Recent Developments
  • 18.3.7. Emulate, Inc.
    • 18.3.7.1. Company Overview
    • 18.3.7.2. Financial Overview
    • 18.3.7.3. Product Portfolio
    • 18.3.7.4. Business Strategies
    • 18.3.7.5. Recent Developments
  • 18.3.8. Newcells Biotech
    • 18.3.8.1. Company Overview
    • 18.3.8.2. Financial Overview
    • 18.3.8.3. Product Portfolio
    • 18.3.8.4. Business Strategies
    • 18.3.8.5. Recent Developments
  • 18.3.9. ACROBiosystems
    • 18.3.9.1. Company Overview
    • 18.3.9.2. Financial Overview
    • 18.3.9.3. Product Portfolio
    • 18.3.9.4. Business Strategies
    • 18.3.9.5. Recent Developments
  • 18.3.10. Corning Incorporated
    • 18.3.10.1. Company Overview
    • 18.3.10.2. Financial Overview
    • 18.3.10.3. Product Portfolio
    • 18.3.10.4. Business Strategies
    • 18.3.10.5. Recent Developments
  • 18.3.11. Pandorum Technologies Pvt. Ltd.
    • 18.3.11.1. Company Overview
    • 18.3.11.2. Financial Overview
    • 18.3.11.3. Product Portfolio
    • 18.3.11.4. Business Strategies
    • 18.3.11.5. Recent Developments
  • 18.3.12. MIMETAS B.V.
    • 18.3.12.1. Company Overview
    • 18.3.12.2. Financial Overview
    • 18.3.12.3. Product Portfolio
    • 18.3.12.4. Business Strategies
    • 18.3.12.5. Recent Developments
  • 18.3.13. Organovo Holdings Inc.
    • 18.3.13.1. Company Overview
    • 18.3.13.2. Financial Overview
    • 18.3.13.3. Product Portfolio
    • 18.3.13.4. Business Strategies
    • 18.3.13.5. Recent Developments
  • 18.3.14. Crown Bioscience
    • 18.3.14.1. Company Overview
    • 18.3.14.2. Financial Overview
    • 18.3.14.3. Product Portfolio
    • 18.3.14.4. Business Strategies
    • 18.3.14.5. Recent Developments
  • 18.3.15. OrganoTherapeutics SARL
    • 18.3.15.1. Company Overview
    • 18.3.15.2. Financial Overview
    • 18.3.15.3. Product Portfolio
    • 18.3.15.4. Business Strategies
    • 18.3.15.5. Recent Developments